These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7723627)

  • 1. Point mutations of mitochondrial genome in Parkinson's disease.
    Ikebe S; Tanaka M; Ozawa T
    Brain Res Mol Brain Res; 1995 Feb; 28(2):281-95. PubMed ID: 7723627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
    Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease.
    Simon DK; Lin MT; Zheng L; Liu GJ; Ahn CH; Kim LM; Mauck WM; Twu F; Beal MF; Johns DR
    Neurobiol Aging; 2004 Jan; 25(1):71-81. PubMed ID: 14675733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
    Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA
    Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of the mitochondrial A7237T mutation in Parkinson's disease.
    Lücking CB; Kösel S; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1995 Jun; 211(2):700-4. PubMed ID: 7794285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease.
    Nido GS; Dölle C; Flønes I; Tuppen HA; Alves G; Tysnes OB; Haugarvoll K; Tzoulis C
    Neurobiol Aging; 2018 Mar; 63():120-127. PubMed ID: 29257976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence analysis of the entire mitochondrial genome in Parkinson's disease.
    Vives-Bauza C; Andreu AL; Manfredi G; Beal MF; Janetzky B; Gruenewald TH; Lin MT
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1593-601. PubMed ID: 11820805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence.
    Ikebe S; Tanaka M; Ohno K; Sato W; Hattori K; Kondo T; Mizuno Y; Ozawa T
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1044-8. PubMed ID: 2390073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of deletions and point mutations in mitochondrial genome in degenerative diseases.
    Tanaka M; Kovalenko SA; Gong JS; Borgeld HJ; Katsumata K; Hayakawa M; Yoneda M; Ozawa T
    Ann N Y Acad Sci; 1996 Jun; 786():102-11. PubMed ID: 8687011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA homeostasis is essential for nigrostriatal integrity.
    Tzoulis C; Schwarzlmüller T; Biermann M; Haugarvoll K; Bindoff LA
    Mitochondrion; 2016 May; 28():33-7. PubMed ID: 26979109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial encephalomyopathy.
    Ozawa T; Tanaka M; Sugiyama S; Ino H; Ohno K; Hattori K; Ohbayashi T; Ito T; Deguchi H; Kawamura K
    Biochem Biophys Res Commun; 1991 May; 177(1):518-25. PubMed ID: 2043137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons.
    Reeve A; Meagher M; Lax N; Simcox E; Hepplewhite P; Jaros E; Turnbull D
    J Neurosci; 2013 Jun; 33(26):10790-801. PubMed ID: 23804100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mitochondrial DNA mutations in Parkinson's disease.
    Richter G; Sonnenschein A; Grünewald T; Reichmann H; Janetzky B
    J Neural Transm (Vienna); 2002 May; 109(5-6):721-9. PubMed ID: 12111463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction.
    Kösel S; Egensperger R; Schnopp NM; Graeber MB
    Mov Disord; 1997 Sep; 12(5):639-45. PubMed ID: 9380043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of a mitochondrial DNA deletion in Parkinson's disease.
    Mann VM; Cooper JM; Schapira AH
    FEBS Lett; 1992 Mar; 299(3):218-22. PubMed ID: 1544498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mitochondria in Parkinson disease.
    Kösel S; Hofhaus G; Maassen A; Vieregge P; Graeber MB
    Biol Chem; 1999; 380(7-8):865-70. PubMed ID: 10494835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.